Anton Tkachenko

Dr. Anton Tkachenko

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Anton TkachenkoAnton Tkachenko
Anton Tkachenko
KKKristyna Kupcova
Kristyna Kupcova
OHOndrej Havranek
Ondrej Havranek
B-cell receptor (BCR) is a B cell hallmark surface complex regulating multiple cellular processes in normal as well as malignant B cells. Igα (CD79a)/Igβ (CD79b) are essential components of BCR that are indispensable for its functionality, signal initiation, and signal transduction. CD79a/CD79b-mediated BCR signaling is required for the survival of normal as well as malignant B cells via a wide signaling network. Recent studies identified the great complexity of this signaling network and revealed the emerging role of CD79a/CD79b in signal integration. In this review, we have focused on functional features of CD79a/CD79b, summarized signaling consequences of CD79a/CD79b post-translational modifications, and highlighted specifics of CD79a/CD79b interactions within BCR and related signaling cascades. We have reviewed the complex role of CD79a/CD79b in multiple aspects of normal B cell biology and how is the normal BCR signaling affected by lymphoid neoplasms associated CD79A/CD79B mutations. We have also summarized important unresolved questions and highlighted issues that remain to be explored for better understanding of CD79a/CD79b-mediated signal transduction and the eventual identification of additional therapeutically targetable BCR signaling vulnerabilities.

30 November 2023 in Apoptosis
Verified
Journal Article
Closed access
PDF file
Anton TkachenkoAnton Tkachenko
Anton Tkachenko

1 July 2025 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
Anton TkachenkoAnton Tkachenko
Anton Tkachenko
MAMohammad A. Alfhili
Mohammad A. Alfhili
JAJawaher Alsughayyir
Jawaher Alsughayyir
Alessandro AttanzioAlessandro Attanzio
Alessandro Attanzio
ABAbdulla Al Mamun Bhuyan
Abdulla Al Mamun Bhuyan
TWThomas Wieder
Thomas Wieder
: Early studies have shown that erythrocytes have caspase-3 and caspase-8 and are capable of dying through an apoptotic-like cell death triggered by Ca2+ ionophores. This cell death is associated with apoptosis-like morphological signs, including cell shrinkage, membrane blebbing, and phosphatidylserine externalization. To emphasize that mature erythrocytes don’t have the apoptotic mitochondrial machinery and distinguish this unique cell death modality from apoptosis, it was named “eryptosis”. Over recent decades, our knowledge of eryptosis has been significantly expanded, providing more insights into the uniqueness of cell death pathways in erythrocytes. In this review, we aim to summarize our current understanding of eryptosis, formulate the nomenclature and guidelines to interpret results of eryptosis studies, provide a synopsis of morphological and biochemical features of eryptosis, and highlight the role of eryptosis in health and disease, including its druggability.

4 April 2024 in Toxicology in Vitro
Verified
Journal Article
Closed access
Anton TkachenkoAnton Tkachenko
Anton Tkachenko

29 October 2022 in Apoptosis
Verified
Journal Article
Closed access
PDF file
Anton TkachenkoAnton Tkachenko
Anton Tkachenko
AOAnatolii Onishchenko
Anatolii Onishchenko

24 November 2022 in Journal of Biomedical Materials Research Part B: Applied Biomaterials
Verified
Journal Article
Closed access
SYSvetlana Yefimova
Svetlana Yefimova
VKVladimir Klochkov
Vladimir Klochkov
NKNataliya Kavok
Nataliya Kavok
Anton TkachenkoAnton Tkachenko
Anton Tkachenko
AOAnatolii Onishchenko
Anatolii Onishchenko
KOKasim Ocakoglu
Kasim Ocakoglu